Cattle Virus Surges, Yet Goat Vaccine Used Despite India's Own Breakthrough Shot
India is risking a severe wave of Lumpy Skin Disease (LSD) outbreaks among cattle by continuing to rely on an outdated vaccine despite having a scientifically proven shot, Dr Naveen Kumar, chief of the National Institute of Virology, Pune, has told News18.
A painful and infectious viral disease, LSD, which primarily affects cattle and water buffalo, is resurging in parts of India, with fresh outbreaks reported in Maharashtra's Pune, Akola, Satara and Buldhana districts. However, the majority of Indian states, despite losing thousands of animals to LSD, are using 'goatpox vaccination' made from the goatpox virus (GTPV).
The goatpox vaccine, as the name suggests, was originally developed for goats. It began to be used in cattle only as a temporary solution when no specific vaccine was available to protect them against the viral LSD. However, that is no longer the case. India, since 2022, has a scientifically proven, indigenous LSD-specific vaccine readily available.
Kumar, who is director of India's premier virology institute and also the lead inventor of India's only LSD-specific vaccine, Lumpi-ProVac, told News18: 'While a safer and efficacious homologous vaccine is available, the country continues to use the goatpox vaccine."
Kumar developed the vaccine during his stint at ICAR's National Research Centre on Equines (NRCE), Hisar, during the outbreak of the Covid-19 pandemic. In 2022, while Kumar and his team pushed for emergency approval of the vaccine, it wasn't able to get through, and India kept on using the goatpox vaccine.
'I isolated an LSD virus during the 2019 outbreak and developed a homologous, live-attenuated vaccine using the Ranchi strain. We developed Lumpi-ProVac, a homologous, live-attenuated vaccine, he said while adding that 'it remains India's only LSD-specific vaccine, offering 100 per cent protection with no adverse effects and far superior safety compared to global Neethling-based vaccines which are associated with adverse side effects such as local swelling, decrease in milk production and fever in up to 15 per cent vaccinated animals".
He recalled the chronology of the making of the vaccine and added that following the controlled experimental trials in calves, the LSD vaccine was tested on more than 2.5 lakh animals in field trials. 'We have published data on 26,900 animals, proving that the vaccine is safe and effective. Otherwise, the requirement for such vaccine approval is testing on around 500-600 animals."
However, he warned that with waning herd immunity from the 2022 wave, a larger outbreak is likely in 2025 if robust vaccination isn't ensured.
Dual vaccine policy creating confusion
Although the Department of Animal Husbandry and Dairying (DAHD) issued a letter on June 11, 2025, allowing the use of the LSD vaccine alongside goatpox, it stopped short of clearly discontinuing goatpox. As a result, most state animal husbandry departments continue prioritising goatpox, citing existing stockpiles and lack of directive.
This has led to confusion among veterinary authorities and state policymakers. 'DAHD must issue clear instructions to phase out goatpox, as it offers limited protection. Moreover, simultaneous use of both vaccines raises the risk of recombination between the GTPV (Uttarkashi strain) and LSDV (Ranchi strain) vaccine viruses, potentially leading to the emergence of a more virulent virus," Kumar pointed out.
Similar concern has been raised by the co-inventor of the vaccine, Dr BN Tripathi, who headed the National Research Centre on Equines (NRCE), Hisar, at the time Kumar invented the vaccine.
'This dual vaccine policy is causing deep confusion among state veterinary authorities," Tripathi, former deputy director general (Animal Science), Indian Council of Agricultural Research, Ministry of Agriculture and Farmers Welfare, told News18.
'Unless DAHD issues clear orders to phase out goatpox, states will keep using it, despite its poor protection. Worse, using both vaccines simultaneously could lead to recombination between the vaccine strains—potentially creating a more virulent virus."
Despite vaccinating over 100 million cattle annually with goatpox since 2021, India has seen no conclusive evidence of its effectiveness. In Maharashtra alone, during the 2022 outbreak, over 4.18 lakh cattle contracted LSD despite being vaccinated, resulting in 32,000 deaths. 'Public spending on goatpox vaccine already exceeds Rs 400 crore annually," Tripathi said.
Why are cattle being given a goat vaccine?
According to veterinary animal scientist Tripathi, the misplaced strategy of using goatpox vaccine instead of Lumpi-ProVac could undo hard-won gains and trigger avoidable livestock losses.
In March, Tripathi, who is now vice-chancellor, Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu, wrote a letter to the Secretary of the Department of Animal Husbandry, 'requesting the consideration for the adoption" of this vaccine.
'I am requesting your consideration for the adoption of this vaccine as soon as possible, given its approval by the Central Drug Standards Control Organisation (CDSCO). Despite this, a group of proponents of the goatpox vaccine has opposed the ICAR LSD vaccine without providing any scientifically valid arguments since its official release on August 10, 2022," wrote Tripathi, calling himself 'co-inventor" of the vaccine.
Tripathi warns that unless mass immunisation with the homologous, live-attenuated vaccine is scaled up immediately, the country could see another devastating outbreak — especially during the monsoon, when hot and humid conditions heighten LSD transmission.
While some officials credit the goatpox vaccine for the current decline in LSD cases, he points out the real reason is 'the temporary herd immunity conferred by the widespread 2022 outbreak". This outbreak killed 165,000 cattle and caused Rs 18,000 crore in economic losses. 'That immunity is now waning, and the goatpox vaccine lacks the immune strength to prevent a resurgence."
Five firms have commercial licenses
Following successful lab trials and large-scale field testing on 2.79 lakh cattle, including pregnant and lactating cows, the vaccine was licensed in 2022 for commercial production. The vaccine produced by Biovet, the Bharat Biotech group, was approved by the drug regulatory authority of India in October 2024, and the vaccine is commercially available with the trade name of 'Biolumpivaxin".
There are five firms which are licensed to manufacture the vaccine, including Biovet, Hester Biosciences, Indian Immunologicals Ltd, IVBP Pune and a Karnataka government firm. 'It costs just Rs 1–2 per dose and has already demonstrated game-changing results in real-world deployments," Tripathi said.
Unlike the goatpox vaccine, Lumpi-ProVac is the world's only DIVA (Differentiating Infected from Vaccinated Animals) marker vaccine, meeting the World Organisation of Animal Health (WOAH) standards. 'This gives India a critical edge for export and positions it to achieve freedom from infection status, which is impossible with goatpox," Tripathi highlighted.
Hailed for 'Chamatkarik Parinam" by CM Yogi
top videos
View all
The vaccine's transformative power was seen at Uttar Pradesh Chief Minister Yogi Adityanath's gaushala in Gorakhpur. Despite two rounds of goatpox vaccination, the LSD outbreak continued in 2023. At the CM's request, the indigenous vaccine was used — and the outbreak was brought under control almost immediately.
'He was informed that while the vaccine is not yet approved, this can be injected. The vaccine showed results and, in fact, at the Indian Veterinary Research Institute (IVRI) convocation on June 30, Yogi praised the vaccine's performance as a 'chamatkarik parinam" (miraculous outcome) and voiced frustration over delays in national rollout."
About the Author
Himani Chandna
Himani Chandna, Associate Editor at CNN News18, specialises in healthcare and pharmaceuticals. With firsthand insights into India's COVID-19 battle, she brings a seasoned perspective. She is particularly pass...Read More
Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated!
view comments
Location :
New Delhi, India, India
First Published:
July 30, 2025, 10:21 IST
News india Cattle Virus Surges, Yet Goat Vaccine Used Despite India's Own Breakthrough Shot
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
39 minutes ago
- News18
12 labourers injured as landslide hits hydel project site in Ukhands Chamoli
Gopeshwar, Aug 2 (PTI) Twelve labourers were on Saturday injured when a landslide hit the THDC's Vinshnugad Hydro-electricity project site near Helang in Uttarakhand's Chamoli district, an official said. District Magistrate Sandeep Tiwari said that there were around 300 labourers at work at the project site when the landslide occurred. They ran for life as a rock began to roll down from a hill. Eight of them sustained minor injuries, while four were seriously injured, he added. The district magistrate said that all injured labourers were admitted to Vivekanand Hospital in Pipalkoti. One of them has got a fracture in the leg, while another labourer on whom a spinal MRI needs to be done is being taken in an ambulance to a hospital in Srinagar in Pauri district, he added. Tiwari said the MRI report will reveal the severity of his injury. The district magistrate further said that there were around 70 labourers present on the spot where the landslide occurred, adding the work has been suspended for the time being at the project site. 'THDC has been asked to resume work at the site only after ensuring the safety of those at work," he said. The THDC is building a barrage to stop the water of Alaknanda river from Helang near Joshimath. The water of Alaknanda river from this barrage will be brought to Pipalkoti through a tunnel where electricity is to be generated through turbines. Earlier in 2021, the barrage side was damaged due to flood in Alaknanda river. PTI Cor ALM AS AS view comments First Published: August 02, 2025, 15:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
an hour ago
- News18
BMRCL facilitates Bengalurus first ever organ transportation by metro
Last Updated: Bengaluru, Aug 2 (PTI) For the first time since its inception, Namma Metro facilitated the transportation of a donated human liver for transplant, the BMRCL said on Saturday. On August 1, at about 8.38 pm, the liver was securely transferred via ambulance from Vydehi Hospital to Whitefield Metro Station, accompanied by a doctor and seven medical staff, the Bangalore Metro Rail Corporation Limited (BMRCL) said in a release. Upon arrival, the team was received by an Assistant Security Officer (ASO) and Metro personnel, who coordinated the documentation and necessary security checks, it added. The liver was then transported on a train that departed Whitefield metro station at 8.42 pm and arrived at Rajarajeshwarinagar Metro Station at 9.48 pm. Another ASO and Metro staff received the medical team and ensured a seamless transfer to a waiting ambulance. The organ was safely delivered to Sparsh Hospital in time for the critical transplant, the release said. The operation followed the guidelines of the Ministry of Housing and Urban Affairs (MoHUA) and Joint Procedure Order (JPO) of the BMRCL. According to the release, this is the second time in the country that a metro train is being used for organ transportation. On January 18, Hyderabad Metro Rail created a dedicated 'green channel", between Kamineni Hospitals in LB Nagar and Gleneagles Global Hospital in Lakdikapul, to facilitate the swift transportation of a donor heart. PTI JR KH (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
an hour ago
- News18
Photos: Adarsh Gourav Attends Alien: Earth's ‘Magical' European Premiere
Last Updated: Adarsh Gourav will be seen as the character Slightly in Noah Hawley's Alien: Earth. Actor Adarsh Gourav walked the red carpet of the European premiere of his upcoming show Alien: Earth on July 29. He is all set to be seen in a completely different role than his usual ones in the sci-fi series. The premiere event took place at the Barbican Centre, London, and the BAFTA-nominated actor graced the red carpet alongside the rest of the cast of the upcoming show. Taking to his Instagram account on Friday, August 1, Adarsh dropped some glimpses from the premiere. In one picture, he was seen with his co-stars Sydney Chandler, Kit Young, Erana James, Jonathan Ajayi, and Lily Newmark, posing on the red carpet. Another few captured some of their behind-the-scenes antics. Through some pictures in the carousel, Adarsh also gave a closer look at his stylish outfit for his red carpet appearance. In the monochrome pictures, he was rocking an all-black look, comprising a half-sleeved leather shirt paired with a tie, a leather jacket and pants. He was seen posing for photos in the streets of London and was even seen giving autographs to fans who gathered at the event. View this post on Instagram A post shared by Adarsh Gourav (@gouravadarsh) Adarsh Gourav Says It Was His 'Privilege' To Work With The Cast Of Alien: Earth In the caption of the post, he wrote, 'The European premiere of @alienearthfx was magical. Such a privilege to work alongside the best talent in the world. Super excited for the show to drop on the 12th of August on @hulu and @disneyplus worldwide." Adarsh's sweet words for the cast of Alien: Earth immediately received reactions from his co-stars. The show's lead actress, Sydney Chandler, reacted to the post with red hearts, whereas his co-star, Babou Ceesay, wrote, 'You're an icon." Actress Diem Camille penned, 'Absolute superstar and heart." The upcoming show, directed by Noah Hawley, is a prequel set two years before the events of the original 1979 film Alien. Alien: Earth will follow the story of a young woman and a group of tactical soldiers who must fight to survive after a mysterious space vessel crash-lands on Earth. The entire series was reportedly filmed in Thailand to immerse viewers in a world that is both completely foreign and familiar. The show, led by Sydney Chandler as Wendy, the first hybrid, features Timothy Olyphant, Alex Lawther, Samuel Blenkin, Essie Davis, Adarsh Gourav, Kit Young, David Rysdahl, Babou Ceesay, Jonathan Ajayi, Erana James, Lily Newmark, and Diem Camille as Siberian, among others. Alien: Earth will premiere on August 12 and after an eight-episode run, will end in September. First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
